ZERO Prostate Cancer



Highlights from the ZERO Summit

ZERO Prostate Cancer Summit

The 2022 ZERO Summit took place on March 4-8 and a big thank you to all participants and sponsors for a very successful event. This record-breaking Summit attracted nearly 1,700 registrants nationwide to join an empowering series of educational sessions, support group lounges, and advocacy initiatives. It was great to see everyone coming together to connect, learn, and support.

The Summit featured nine live educational sessions, 14 on-demand videos, 10 support group lounges, four chapter lounges, the Bold for Blue Awards, and a comedy segment. Advocacy efforts included 137 advocates hosting 172 meetings with key policymakers.

Good news! If you missed the Summit, or if you took part and want to see any of it again, the on-demand videos and the educational sessions will be posted until March 31. If you registered already, please access the platform using the personal login information that was emailed to you. If you did not register, you can still view the Summit videos by clicking the registration link below. Next year's Summit is already scheduled for February 26-28, so mark your calendars. The event will be both virtual and in-person.

Register To Watch The Summit Videos

Celebrate Our Inspiring Bold for Blue Award Winners

Bold for Blue Awards

On March 4, the ZERO Summit started on a celebratory note with the Bold for Blue Awards, paying tribute to exceptional people and organizations serving the prostate cancer community. Congratulations and a heartfelt thank you to this year's winners:

Legacy Winner:
Us TOO International

Impact Winners:
Ryan Pessah, Landi Maduro, and Don Williamson

The Edward C. Kaps Hope Award Winners:
Kathie and Dave Houchens, Jerry Deans, and Anthony Pizzoferrato

Caesar Blevins Warrior Award Winner:
Jim Wilhelmsen

Megaphone Award Winner:
Jay Jay French

Top Corporate Fundraisers:
AutoNation, Pfizer, Bayer, Tito's, and Baird

Top Fundraisers:
Sandy Maxey, Bill Miller, Susie Schlernitzauer, Karen Jauregui, The Forsburg 40 - ZERO's largest Run/Walk Team, Team Nikituk, Jack Porter, Ryan and Anna Pessah, Team Angus led by Mark Hagenbuch, Robert Ferrari, Sue and Nancy of the Ripple Run, Dan Perkins, Catherine Hawley, Michael Bachmann, and Darik Pearson

Click the link below to read the amazing stories of these inspirational members of the prostate cancer community, learn about the awards, and watch video of the full Bold for Blue Awards. There were many emotional moments that you need to see which really drive home why we are all here, and why we all do what we do.

See Bold For Blue

Register for the 2022 ZERO Run/Walk

ZERO Prostate Cancer Run Walk

Exciting news! Registration is open for the 2022 ZERO Prostate Cancer Run/Walk series. Sign up for one of 47 in-person events that are currently scheduled all over the country, with the first taking place on May 15 in Los Angeles. You will love the support and camaraderie that you will find at the Run/Walk events. All money raised as part of these events will go to help those affected by prostate cancer.

Register Here

Tee-Off Against Prostate Cancer

Tee Off in the Fight Against Prostate Cancer

Sign up to be a part of the ZERO Prostate Cancer Tee-Off at Topgolf. There's no pressure to have a good golf swing, it's all about everyone having fun. Grab a club and take a swing at the micro-chipped balls to see how many points you can rack up. All proceeds benefit prostate cancer patients and families. If you are in the area, be sure to register for these upcoming events:

March 20, 2:00 p.m. Eastern
Topgolf Edison
1013 U.S. Rt. 1
Edison, NJ 08817

March 27, 2:00 p.m. Eastern
Topgolf Alpharetta
10900 Westside Parkway
Alpharetta, GA 30009

May 1, 2:00 p.m. Eastern
Topgolf Miami-Doral
11850 NW 22nd Street
Doral, FL 33182

Sunday, May 15, 2022, 2:00 p.m. Eastern
Topgolf Tampa
10690 Palm River Rd.
Tampa, FL 33619

June 6, 7:45 a.m. Central
The Legacy Golf Club
400 Legacy Pkwy
Norwalk, IA 50211

June 16, 5:00 p.m. Central
Topgolf Allen
1500 Andrews Parkway
Allen, TX 75002

New Resources for You

Man on computer

Two great new resources have been added to the ZERO Fact Sheets and Literature webpage. The Prostate Cancer Fact Sheet provides you with some new facts, stats, and numbers related to prostate cancer. About Prostate Cancer offers you a very brief and practical general overview of the disease, from testing, through diagnosis and treatment, and on to survivorship. Be sure to share this valuable information with your friends, colleagues, and family members.

Join a Webinar

Join a Webinar

March 17, 6:00 p.m. Eastern Time
Your Prostate in the Metaverse - the Future of Prostate MRI
with Daniel J. A. Margolis, MD, Associate Professor of Radiology; Director, Prostate MRI; Weill Cornell Medicine

April 28, 6:30 p.m. - 7:30 p.m. Eastern Time
2022 American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium Research Updates
with Dr. Alexandra Sokolova, Assistant Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine, Oregon Health and Science University

Special Two Part Series - Register for Either One or Both
Brought to you in partnership with Boston Scientific

May 10, 7:00 p.m. Eastern Time
Signs, Symptoms, and Treatment Options for Erectile Dysfunction and Incontinence (Part 1 of 2)
with Dr. Michael Granieri, Urologist, Conrad Pearson Clinic

May 19, 7:00 p.m. Eastern Time
Prostate Cancer Treatment Options and Risk Mitigation for Radiation Therapy (Part 2 of 2)
with Dr. Albert Chang, Radiation Oncologist, UCLA Health

What prostate cancer support and education events are happening this month? Check the calendar! The Prostate Cancer Calendar web page is a resource for the entire prostate cancer community. If you are looking for a prostate cancer event, please check the calendar. If you have a support group, webinar, seminar, or other prostate cancer event that will benefit the community, you can post it right to the calendar.

Get Between the Sheets


The bi-monthly Between the Sheets column provides a platform for experts to help men and women by providing answers to questions about sexual health and intimacy challenges that can result from prostate cancer treatment. In this issue, Dr. Anne Katz, Certified Sexuality Counselor and Clinical Nurse Specialist at CancerCare Manitoba, addresses a question from a man who feels a loss of intimacy with his wife due to the side effects of erectile dysfunction and incontinence after prostate cancer treatment.

Read Between the Sheets

Progress in Prostate Cancer Research

Prostate Cancer Research

Advancements in prostate cancer research provide hope for finding a cure and lead to important new discoveries. Progress in Prostate Cancer Research is a ZEROHour feature that includes some of the latest research from the Prostate Cancer Foundation (PCF). This month, read Highlights of ASCO GU 2022: Combination Treatments for Metastatic Disease; ARASENS Trial Results: Triplet Treatment of Metastatic Hormone-Sensitive Prostate Cancer; and MAGNITUDE Trial Results: A Novel Combination Against Metastatic Castration-Resistant Prostate Cancer.

Read the Latest

Read Doc Moyad's "No Bogus Science" Column

Doc Moyad

For over 15 years and almost 200 consecutive columns, Dr. Mark A. Moyad of University of Michigan Medical Center, Department of Urology has volunteered to write for Us TOO's Hot SHEET newsletter with the hopes of offering some very practical advice to improve health outcomes. In the latest issue, he looks at the recent encouraging news on vitamin D supplements, but not to prevent what many might expect, and there is a greater lesson here.

Read Doc Moyad

Listen to a Prostate Cancer Podcast

Couple on couch

Check out the latest Prostate Cancer Real Talk podcast, Episode 10: "Why are Black Men Affected More?" with Dr. Adam Murphy, Urologist at Northwestern Hospital in Chicago, IL.

Listen Now


Zero Us TOO Prostate Cancer Support Groups

Virtual US TOO Support Groups

ZERO/Us TOO has virtual prostate cancer support groups that continue to meet regularly and host guest speakers. These meetings can be accessed by phone or by internet, and can be attended from any location. » Find a support group.

Champions Corner

Dan Leonard

Meet Dan Leonard

Dan Leonard is a survivor, instrumental supporter of the Sacramento Run/Walk, and is passionate about spreading awareness in the local community through his deep involvement with the Triumph Cancer Foundation. "It's important to give back. Being healthy and fortunate all of my life I, as well as too many others, witnessed the travesty of cancer among family and friends." » Join patients like Dan at a ZERO Run/Walk near you

LiveStream Fundraising

Mazer Gaming Logo

Bringing eSports to ZERO

Pro competitors Mazer Gaming say they're happy to be, "Supporting ZERO's amazing mission to end prostate cancer through donations during our streamed events that will help raise awareness through gaming." Are you a gamer? A chef? A musician? An exercise buff? A comedian? Wherever your talent lies, you can put your creativity on display to help spread the word that will save lives! CLICK HERE to learn more on how to help end prostate cancer through livestreaming.



Talapro 3

Have you been diagnosed with metastatic castration-sensitive prostate cancer? Do you have a DNA Damage Repair (DDR) gene alteration? You may be eligible to take part in a clinical trial studying a potential treatment for this type of cancer. The TALAPRO-3 trial is evaluating whether talazoparib (the study drug) when taken with enzalutamide, an existing approved treatment for metastatic prostate cancer, can help keep tumors under control for longer than enzalutamide taken with placebo (an inactive medication). The trial will also explore the safety of this drug combination. » Read more. (This content is provided in partnership with Pfizer Oncology).




Do you have metastatic Castration-Resistant Prostate Cancer (mCRPC)? Are you ineligible or electing not to receive treatment with chemotherapy? If so, then you may be eligible for the SPLASH clinical trial. This trial is for patients who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT) and who haven't yet received chemotherapy. The SPLASH trial is now enrolling to evaluate if [Lu-177]-PNT2002, a radioligand therapy (RLT), is a safe and effective option to slow down the progression of mCPRC. More information about the trial is available on the website. » Read more. (This content is provided in partnership with POINT Biopharma).

This newsletter is brought to you in partnership with Advanced Accelerator Applications.

Advanced Accelerator Applications


515 King Street
Suite 310
Alexandria, VA 22314

privacy policy



Join our mailing list to get the latest in prostate cancer news, events, advocacy, and community!


© 2024 ZERO Prostate Cancer. All rights reserved. ZERO is a 501(c)(3) non-profit organization.